Publicaciones en las que colabora con DANIEL SABATER HERNÁNDEZ (29)

2016

  1. Fiabilidad y validez externa de un cuestionario de conocimiento sobre riesgo y enfermedad cardiovascular en pacientes que acuden a farmacias comunitarias de España

    Atencion Primaria, Vol. 48, Núm. 9, pp. 586-595

2013

  1. Atención farmacéutica

    Fundamentos de farmacología básica y clínica (Editorial Médica Panamericana), pp. 425-442

  2. Effect of a pharmacist intervention on asthma control. A cluster randomised trial

    Respiratory Medicine, Vol. 107, Núm. 9, pp. 1346-1355

  3. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study

    Research in Social and Administrative Pharmacy, Vol. 9, Núm. 6, pp. 797-805

  4. Investigación y conocimiento en Atención Farmacéutica: un binomio inseparable

    Ars pharmaceutica, Vol. 54, Núm. 2, pp. 1-3

2012

  1. Agreement Between Community Pharmacy and Ambulatory and Home Blood Pressure Measurement Methods to Assess the Effectiveness of Antihypertensive Treatment: The MEPAFAR Study

    Journal of Clinical Hypertension, Vol. 14, Núm. 4, pp. 236-244

  2. Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients

    American Journal of Health-System Pharmacy, Vol. 69, Núm. 15, pp. 1311-1318

  3. Errors in turbuhaler technique in a Spanish population of asthmatic patients

    Respiratory Care

  4. Is the inhaler technique associated with asthma control?

    Journal of Asthma

  5. Research and publish in pharmaceutical care: A mission for improve and develop

    Vitae

  6. Terms used in patient safety related to medication: A literature review

    Pharmacoepidemiology and Drug Safety, Vol. 21, Núm. 8, pp. 799-809

  7. Usefulness of blood pressure measurement by community pharmacists in the management of hypertension

    Journal of Managed Care Pharmacy

2011

  1. Efecto de la intervención farmacéutica en la adherencia a la medicación y el control de la presión arterial en pacientes hipertensos tratados: justificación, diseño y los métodos del estudio piloto AFenPA

    Ars pharmaceutica, Vol. 52, Núm. 4, pp. 29-38

  2. Evaluation of the hypertensive state in treated patients: Selection of appropriate blood pressure measurements per visit to the community pharmacy

    Blood Pressure Monitoring, Vol. 16, Núm. 3, pp. 103-110

  3. Magnitude of the white-coat effect in the community pharmacy setting: The MEPAFAR study

    American Journal of Hypertension, Vol. 24, Núm. 8, pp. 887-892

  4. Métodos de medida de la presión arterial disponibles en la farmacia comunitaria para el cribado y seguimiento de la hipertensión arterial

    Pharmaceutical care España, Vol. 13, Núm. 3, pp. 123-133

  5. Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study

    International Journal of Clinical Pharmacy, Vol. 33, Núm. 3, pp. 582-589

  6. Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use

    International Journal of Clinical Pharmacy

2010

  1. Clinical value of blood pressure measurement in the community pharmacy

    Pharmacy World and Science, Vol. 32, Núm. 5, pp. 552-558

  2. Intervención farmacéutica sobre el uso de antiagregantes plaquetarios en diabéticos tipo 2

    Farmacéuticos comunitarios, Vol. 2, Núm. 4, pp. 135-138